Veronika Sexl

Overview

Best Publications

• Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

  Christoph S.N. Klose;Christoph S.N. Klose;Melanie Flach;Melanie Flach;Luisa Möhle;Leif Rogell;Leif Rogell;Leif Rogell

  1187
  Citations

• Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells

  Richard Moriggl;David J Topham;Stephan Teglund;Veronika Sexl

  712
  Citations

• Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

  Mangeng Cheng;Veronika Sexl;Charles J. Sherr;Martine F. Roussel

  687
  Citations

• A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.

  Karoline Kollmann;Gerwin Heller;Christine Schneckenleithner;Wolfgang Warsch

  348
  Citations

• Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.

  Jing Ni;Jing Ni;Xi Wang;Ana Stojanovic;Ana Stojanovic;Qin Zhang

  310
  Citations

• Stat5 tetramer formation is associated with leukemogenesis

  Richard Moriggl;Veronika Sexl;Lukas Kenner;Christopher Duntsch

  292
  Citations

• Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.

  Andrea Hoelbl;Christian Schuster;Boris Kovacic;Bingmei Zhu

  285
  Citations

• Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation

  Andrea Hoelbl;Boris Kovacic;Marc A. Kerenyi;Olivia Simma

  270
  Citations

• Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

  Veronika Sexl;Roland Piekorz;Richard Moriggl;Juerg Rohrer

  263
  Citations

• Stat5 Activation Is Uniquely Associated with Cytokine Signaling in Peripheral T Cells

  Richard Moriggl;Veronika Sexl;Roland Piekorz;David Topham

  247
  Citations

• Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression

  Monika Linke;Ha Thi Thanh Pham;Karl Katholnig;Thomas Schnöller

  231
  Citations

• High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.

  Wolfgang Warsch;Karoline Kollmann;Eva Eckelhart;Sabine Fajmann

  231
  Citations

• A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development

  Eva Eckelhart;Wolfgang Warsch;Eva Zebedin;Olivia Simma

  231
  Citations

• STIMULATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE VIA THE A2A-ADENOSINE RECEPTOR IN PRIMARY HUMAN ENDOTHELIAL CELLS

  Veronika Sexl;Gudrun Mancusi;Christoph Höller;Eva Gloria-Maercker

  230
  Citations

• NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

  Ariella Glasner;Assi Levi;Jonatan Enk;Batya Isaacson

  224
  Citations

• BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia

  Oliver Hantschel;Oliver Hantschel;Wolfgang Warsch;Eva Eckelhart;Ines Kaupe

  222
  Citations

• CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.

  Ruth Scheicher;Andrea Hoelbl-Kovacic;Florian Bellutti;Anca-Sarmiza Tigan

  215
  Citations

• Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells

  Carmen Streicher;Alexandra Heyny;Olena Andrukhova;Barbara Haigl

  208
  Citations

• Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse

  Dontscho Kerjaschki;Zsuzsanna Bago-Horvath;Margaretha Rudas;Veronika Sexl;Veronika Sexl

  207
  Citations

• O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies

  P Freund;M A Kerenyi;M Hager;T Wagner

  52
  Citations